Robert I. Tepper, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 49,554 shares at $24.34 ($1.2M) on 2017-10-04, disclosed to the SEC on 2017-10-04.
Open-market sale of $1.2M CTMX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.34 | 24,777 | $603K | 50.0% |
| 2 | $24.34 | 24,777 | $603K | 50.0% |
| Total | $24.34 avg | 49,554 | $1.2M | 100% |
| Filing → |
| RVMD | SELL | 2021-06-07 | $32.8M | — | Filing → |
| RLAY | SELL | 2021-01-14 | $312.2M | — | Filing → |
| JNCE | SELL | 2020-11-23 | $105K | — | Filing → |